Document is current
Any future updates will be listed below
-
Authors
Aboharb, Farid
Davoudian, Pasha A. https://orcid.org/0000-0002-5096-7610
Shao, Ling-Xiao https://orcid.org/0009-0006-9503-1230
Liao, Clara
Rzepka, Gillian N.
Wojtasiewicz, Cassandra
Indajang, Jonathan
Dibbs, Mark https://orcid.org/0000-0002-4341-361X
Rondeau, Jocelyne
Sherwood, Alexander M.
Kaye, Alfred P.
Kwan, Alex C. https://orcid.org/0000-0003-2169-1667
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (R01MH121848, R01MH128217, R01MH137047)
- License Information
-
More Information
Article History
Received: 19 April 2024
Accepted: 31 January 2025
First Online: 12 February 2025
Competing interests
: A.C.K. has been a scientific advisor or consultant for Boehringer Ingelheim, Empyrean Neuroscience, Freedom Biosciences, and Xylo Bio. A.C.K. has received research support from Intra-Cellular Therapies. A.P.K has received research support from Transcend Therapeutics and Freedom Biosciences. A.P.K. has a provisional patent application related to psychedelics. The remaining authors declare no competing interests.
